Adding Pressure BioSciences (PBIO) $0.80 to Watch List.

Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues. Photo Ric Schumacher CEO

Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.

Hepion Pharmaceuticals (HEPA) to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)

Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better...

Adding Cardiol Therapeutics (CRDL) $0.59 to Watch List.

Adding to 2023 Biotech Stock Review Watch List. We Think This One Has Legs. Starting Due Diligence...

Topical PTSD Drug Poised for Human Trials.

In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid...
Internet Stock Review, Biotech Stock Review, Roland Rick Perry

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.

Quick way to Jinx Things... Stormin..Live Quote We're still not...

With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case for Its Diabetes...

We always find it Interesting when a Company with a $130 billion market cap (Sanofi: SNY), teams up with a Company...

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...